ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,417Medicare Part D Prescriptions Filled, Including Refills

Rank: 50 out of 617

$544K Total Retail Price of All Prescriptions

Rank: 70 out of 617

509 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
34% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 509 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

8% of this provider’s 509 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 11,534 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
AMLODIPINE BESYLATE 606 566 1 6
OMEPRAZOLE 597 565 2 3
SIMVASTATIN 589 545 3 2
LEVOTHYROXINE SODIUM 471 424 4 1
LISINOPRIL 464 441 5 5
FUROSEMIDE 417 414 6 4
METFORMIN HCL 301 243 7 9
POTASSIUM CHLORIDE 291 285 8 10
SERTRALINE HCL 228 189 9 20
HYDROCODONE-ACETAMINOPHEN 227 214 S3 10 8
CARVEDILOL 222 219 11 19
WARFARIN SODIUM 221 209 12 7
METOPROLOL TARTRATE 213 213 13 11
HYDROCHLOROTHIAZIDE 184 169 14 13
TAMSULOSIN HCL 176 176 15 26
GLYBURIDE 159 141 R 16 84
NAMENDA 157 153 17 35
ALLOPURINOL 153 153 18 27
DONEPEZIL HCL 144 144 19 30
TRAMADOL HCL 136 136 20 15
METOPROLOL SUCCINATE 133 129 21 12
DIOVAN 130 120 22 41
ATORVASTATIN CALCIUM 127 119 23 14
GABAPENTIN 117 117 24 16
ENALAPRIL MALEATE 113 113 25 34
LOSARTAN-HYDROCHLOROTHIAZIDE 105 105 26 46
CLOPIDOGREL 104 89 27 53
CRESTOR 103 93 28 28
LOSARTAN POTASSIUM 101 101 29 22
PRAVASTATIN SODIUM 100 89 30 21
CELEBREX 97 97 31 63
ADVAIR DISKUS 96 87 32 38
PANTOPRAZOLE SODIUM 96 95 32 37
FENTANYL 90 90 S2 34 45
ALENDRONATE SODIUM 87 87 35 25
ZOLPIDEM TARTRATE 86 86 36 23
ALBUTEROL SULFATE 84 84 37 112
AMITRIPTYLINE HCL 81 81 R 38 56
GLIPIZIDE ER 77 77 39 94
MELOXICAM 77 77 39 24
DIOVAN HCT 73 69 41 97
ATENOLOL 72 72 42 17
LISINOPRIL-HYDROCHLOROTHIAZIDE 70 66 43 29
SPIRONOLACTONE 67 63 44 42
IPRATROPIUM BROMIDE 67 67 44 136
RANITIDINE HCL 65 64 46 40
PROAIR HFA 63 56 47 75
PLAVIX 62 58 48 86
DETROL LA 62 50 48 127
POLYETHYLENE GLYCOL 3350 62 61 48 32
ISOSORBIDE MONONITRATE ER 60 60 51 52
LANTUS 60 60 51 39
CIPROFLOXACIN HCL 60 56 51 60
PREDNISONE 57 55 54 31
CARBIDOPA-LEVODOPA 56 56 55 69
VESICARE 55 55 56 95
NEXIUM 55 31 56 43
DIGOXIN 54 54 58 48
QUETIAPINE FUMARATE 51 51 59 78
CITALOPRAM HBR 50 46 60 18
TERAZOSIN HCL 50 39 60 96
HUMALOG 50 50 60 152
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 17, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.